CIK 0001420565 · Non-accelerated filer<br>Smaller reporting company
Rein Therapeutics, Inc.
Sign in to watch- Ticker
- RNTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 134196017
- Phone
- 7378021989
- Business address
- 12407 N. MOPAC EXPY., SUITE 250 #390, AUSTIN, TX, 78758
- Former names
- Aileron Therapeutics, Inc., AILERON THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 51 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-03-13 | Novartis Bioventures Ltd 10% owner | Sale | −132,738 | $2.12 | $281K | 2,264,144 |
| 2019-02-25 | Gregory Kathryn SVP, Chief Business Officer | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2018-08-20 | Novartis Bioventures Ltd 10% owner | Sale | −20,388 | $2.30 | $47K | 2,396,882 |
| 2018-08-17 | Novartis Bioventures Ltd 10% owner | Sale | −8,700 | $2.10 | $18K | 2,417,270 |
| 2018-08-16 | Novartis Bioventures Ltd 10% owner | Sale | −8,808 | $2.10 | $18K | 2,425,970 |
| 2018-08-15 | Novartis Bioventures Ltd 10% owner | Sale | −2,635 | $2.15 | $6K | 2,434,778 |
| 2018-08-14 | Novartis Bioventures Ltd 10% owner | Sale | −3,300 | $2.26 | $7K | 2,437,413 |
| 2018-08-13 | Novartis Bioventures Ltd 10% owner | Sale | −1,600 | $2.36 | $4K | 2,440,713 |
| 2018-08-10 | Novartis Bioventures Ltd 10% owner | Sale | −5,615 | $2.44 | $14K | 2,442,313 |
| 2018-08-09 | Novartis Bioventures Ltd 10% owner | Sale | −235 | $2.48 | $583 | 2,447,928 |
| 2018-08-08 | Novartis Bioventures Ltd 10% owner | Sale | −1,000 | $2.78 | $3K | 2,448,163 |
| 2018-08-07 | Novartis Bioventures Ltd 10% owner | Sale | −1,739 | $2.97 | $5K | 2,449,163 |
| 2018-08-06 | Novartis Bioventures Ltd 10% owner | Sale | −2,942 | $3.02 | $9K | 2,450,902 |
| 2018-08-02 | Novartis Bioventures Ltd 10% owner | Sale | −4,702 | $3.33 | $16K | 2,453,844 |
| 2018-08-01 | Novartis Bioventures Ltd 10% owner | Sale | −8,181 | $3.22 | $26K | 2,458,546 |
| 2018-07-31 | Novartis Bioventures Ltd 10% owner | Sale | −4,500 | $3.07 | $14K | 2,466,727 |
| 2018-07-30 | Novartis Bioventures Ltd 10% owner | Sale | −2,000 | $3.27 | $7K | 2,471,227 |
| 2018-07-27 | Novartis Bioventures Ltd 10% owner | Sale | −6,458 | $3.38 | $22K | 2,473,227 |
| 2018-07-26 | Novartis Bioventures Ltd 10% owner | Sale | −7,937 | $3.63 | $29K | 2,479,685 |
| 2018-07-25 | Novartis Bioventures Ltd 10% owner | Sale | −12,460 | $3.84 | $48K | 2,487,622 |
Page 9 of 10 · 192 trades